Yahoo Web Search

Search results

    • Aptose Reports Results for the First Quarter 2024

      Digital Journal· 4 hours ago

      TUS+VEN+HMA Triplet Protocol in 1L Therapy for Newly Diagnosed AML was Submitted to the FDA During Q1 and is Now Being Activated at Clinical Sites TUS+VEN+HMA Triplet 1L Therapy ...